This resolution reaffirms the freedom to decide on reproductive health and expresses continued support for medication abortion access, addressing concerns about efforts to restrict abortion nationwide. It specifically highlights the potential misuse of the Comstock Act , asserting that its settled understanding does not apply to lawful abortions and that misinterpretation could threaten medical material shipping. The resolution formally affirms the existing authority to distribute medication abortion under federal law, citing a December 2022 Department of Justice Office of Legal Counsel memorandum. Furthermore, it condemns restrictions on both access to and coverage of reproductive health care, explicitly including medication abortion like mifepristone. The resolution emphasizes the safety and effectiveness of medication abortion as a healthcare option.